Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients (PERICO)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Hospital Carlos III, Madrid.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Hospital Carlos III, Madrid
Information provided by:
Hospital Carlos III, Madrid
ClinicalTrials.gov Identifier:
NCT00526448
First received: September 5, 2007
Last updated: January 28, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2010 |
| Estimated Primary Completion Date: | No date given |
No publications provided by Hospital Carlos III, Madrid
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):